These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34970423)

  • 1. Identification of
    Zhu Y; Lin X; Zang Y; Yang Q
    J Healthc Eng; 2021; 2021():4372373. PubMed ID: 34970423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTEN mutation: A potential prognostic factor associated with immune infiltration in endometrial carcinoma.
    Tao Y; Liang B
    Pathol Res Pract; 2020 Jun; 216(6):152943. PubMed ID: 32279917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc Finger E-Box Binding Homeobox 2 as a Prognostic Biomarker in Various Cancers and Its Correlation with Infiltrating Immune Cells in Ovarian Cancer.
    Kim HR; Seo CW; Han SJ; Lee JH; Kim J
    Curr Issues Mol Biol; 2022 Mar; 44(3):1203-1214. PubMed ID: 35723302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of ZEB2-AS1 promotes epithelial-to-mesenchymal transition and metastasis by stabilizing ZEB2 mRNA in head neck squamous cell carcinoma.
    Diao P; Ge H; Song Y; Wu Y; Li J; Li Z; Yang J; Wang Y; Cheng J
    J Cell Mol Med; 2019 Jun; 23(6):4269-4280. PubMed ID: 30950191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma.
    Lai J; Xu T; Yang H
    BMC Cancer; 2022 Mar; 22(1):325. PubMed ID: 35337291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of epithelial-mesenchymal transition factors in the histogenesis of uterine carcinomas.
    Franceschi T; Durieux E; Morel AP; de Saint Hilaire P; Ray-Coquard I; Puisieux A; Devouassoux-Shisheboran M
    Virchows Arch; 2019 Jul; 475(1):85-94. PubMed ID: 30739164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Significance of Zinc Finger E-Box-Binding Homeobox Family in Glioblastoma.
    Chen P; Liu H; Hou A; Sun X; Li B; Niu J; Hu L
    Med Sci Monit; 2018 Feb; 24():1145-1151. PubMed ID: 29476046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide analysis of endogenously expressed ZEB2 binding sites reveals inverse correlations between ZEB2 and GalNAc-transferase GALNT3 in human tumors.
    Balcik-Ercin P; Cetin M; Yalim-Camci I; Odabas G; Tokay N; Sayan AE; Yagci T
    Cell Oncol (Dordr); 2018 Aug; 41(4):379-393. PubMed ID: 29516288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR‑498 inhibits the growth and metastasis of liver cancer by targeting ZEB2.
    Zhang X; Xu X; Ge G; Zang X; Shao M; Zou S; Zhang Y; Mao Z; Zhang J; Mao F; Qian H; Xu W
    Oncol Rep; 2019 Mar; 41(3):1638-1648. PubMed ID: 30592286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ETS1 is coexpressed with ZEB2 and mediates ZEB2-induced epithelial-mesenchymal transition in human tumors.
    Yalim-Camci I; Balcik-Ercin P; Cetin M; Odabas G; Tokay N; Sayan AE; Yagci T
    Mol Carcinog; 2019 Jun; 58(6):1068-1081. PubMed ID: 30790340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Selected Epithelial-Mesenchymal Transition Transcription Factors in Endometrial Cancer.
    Sadłecki P; Jóźwicki J; Antosik P; Walentowicz-Sadłecka M
    Biomed Res Int; 2020; 2020():4584250. PubMed ID: 33457409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishing a Prognostic Signature Based on Epithelial-Mesenchymal Transition-Related Genes for Endometrial Cancer Patients.
    Liu J; Cui G; Shen S; Gao F; Zhu H; Xu Y
    Front Immunol; 2021; 12():805883. PubMed ID: 35095892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein expression of ZEB2 in renal cell carcinoma and its prognostic significance in patient survival.
    Fang Y; Wei J; Cao J; Zhao H; Liao B; Qiu S; Wang D; Luo J; Chen W
    PLoS One; 2013; 8(5):e62558. PubMed ID: 23658743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNF183 Is a Prognostic Biomarker and Correlates With Tumor Purity, Immune Infiltrates in Uterine Corpus Endometrial Carcinoma.
    Geng R; Zheng Y; Zhao L; Huang X; Qiang R; Zhang R; Guo X; Li R
    Front Genet; 2020; 11():595733. PubMed ID: 33324448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Title Prognosis Significance of ZEB2 and TGF-β1 as well as Other Clinical Characteristics in Epithelial Ovarian Cancer.
    Yan Z; Tian X; Wang R; Cheng X; Mi J; Xiong L; Wang Y; Deng J; Jia M
    Int J Gynecol Cancer; 2017 Sep; 27(7):1343-1349. PubMed ID: 30814239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of long non-coding RNA ZEB2-AS1 and EMT-related markers in ductal and lobular breast cancer.
    Zarei M; Malekzadeh K; Omidi M; Mousavi P
    Cancer Rep (Hoboken); 2023 May; 6(5):e1826. PubMed ID: 37088469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated analysis of tumor mutation burden and immune infiltrates in endometrial cancer.
    Zhou H; Chen L; Lei Y; Li T; Li H; Cheng X
    Curr Probl Cancer; 2021 Apr; 45(2):100660. PubMed ID: 33012523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of immune landscape in tumour microenvironment of endometrial cancer.
    Li BL; Wan XP
    J Cell Mol Med; 2020 Jul; 24(14):7767-7777. PubMed ID: 32424934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [miR-367-3p Regulates Cells Proliferation and Invasion in NSCLC by Targeting ZEB2].
    Su Y; Zhang H
    Zhongguo Fei Ai Za Zhi; 2022 Nov; 25(11):782-788. PubMed ID: 36419391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.